What's better than momentum? Mo' momentum.
Let's take a closer look at five of this past week's biggest scorchers.
Company |
Sep. 9 |
Weekly Gain |
My Watchlist |
---|---|---|---|
Caliper Life Sciences |
$10.45 |
48% |
|
Temple-Inland |
$31.05 |
26% |
|
Ulta Salon |
$68.45 |
24% |
|
Optimer Pharmaceuticals |
$11.93 |
21% |
|
Talbots |
$2.83 |
18% |
Source: Barron's.
There was new life at Caliper after the maker of molecular imaging and detection technologies for life sciences research and diagnostics agreed to a buyout. PerkinElmer
Playing hard to get paid off for Temple-Inland. The maker of corrugated packaging and building products originally shot down International Paper's
Ulta Salon colored out some of its gray hairs after posting better-than-expected quarterly results. The cosmetics retailer and beauty salon operator saw earnings skyrocket 73% to $0.38 a share, well ahead of the $0.32 a share analysts were expecting. Revenue climbed 23%, with roughly half of that coming from an impressive 11.3% spurt in comparable-store sales .Optimer announced that 11 abstracts reporting new research findings for its fidaxomicin tablets will be presented at a conference in Chicago this weekend. Optimer's drug was approved by the FDA for treatment of diarrhea associated with Clostridium difficile in adults back in May.
Finally, there's Talbots. The frumpy retailer may have posted a wider-than-expected loss on plunging sales, but the market cheered when the chain revealed that it would be hiring a new chief creative officer. Given Talbots' struggles lately, the reinvention process will be challenging but necessary.
It was a great week for these five stocks. Now let's see if they're up for an encore.
Which of these five stocks do you think will continue to move higher? Share your thoughts in the comment box below.